NNovo Nordisk Read More Can LLY’s Expanding Obesity Pipeline Sustain Its GLP-1 Leadership?2026-11-13 Eli Lilly and Company LLY has established itself as a dominant player in the rapidly expanding obesity treatment…
NNovo Nordisk Read More Lilly Stock Near A High: What Can Democrats Change?2026-11-03 For questions about this article or underlying research, email help@trefis.com. Part of our midterms guide. Start here: what…
NNovo Nordisk Read More Better High-Yield Dividend Stock: Pfizer or Novo Nordisk?2026-10-06 Key Points Novo Nordisk is a leading GLP-1 company, but its portfolio beyond that is limited. Pfizer hasn’t…
NNovo Nordisk Read More Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded?2026-09-16 Key Points Novo Nordisk has lost its lead in the weight loss market. The company could face even…
NNovo Nordisk Read More In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s2026-07-16 The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly LLY 1.15%increase; up…
BBrussels Read More Unbowed Orbán Returns to Brussels, Declares Patriots’ Surge Unstoppable 2026-06-18 Former Hungarian Prime Minister Viktor Orbán made his first official trip abroad since Fidesz lost power in April,…
NNovo Nordisk Read More What’s Next For Novo Nordisk Stock?2026-02-24 Novo Nordisk’s stock fell 16% on February 23rd after clinical trial results showed that its experimental weight-loss pill,…